Our study provides the evidence that ribavirin in combination with IFN-α can significantly inhibit the proliferation and migration, induce apoptosis, arrest the cell cycle at the G2/M phase, and decrease IL-10 production in the RCC cell lines. Here, IL10 is linked to renal cell carcinoma.